glp-1 and substance use disorder Weight Loss Drugs May Also Curb Disorders GLP-1 Drugs and the Physiology

U.S.: 71%), followed by metabolic health/diabetes

Exploring the Potential of MSC Therapy in Cardiovascular Health: What Patients Should Know June 25, 2025 A New Frontier in Cardiovascular Health Cardiovascular disease remains the leading cause of death in the United States, with atherosclerosischaracterized by plaque buildup in the arteriesplaying a central role

The April 30, 2026 503B bulks-list exclusion proposal targets large outsourcing facilities, not patient-specific 503A telehealth

However, implementation of this model in Medicare faces an uncertain future, since CMS has not yet announced specific plans to restart or restructure the model for future years

Up to 24.2% body weight reduction over 48 weeks